.jpg?format=webp&quality=80&width=3840)
Uncertainty exists regarding the risks of adverse pregnancy outcomes for patients with axial spondyloarthritis (axSpA) owing to a lack of high-quality evidence. Reassuringly, however, the results of a large register-based cohort study highlight that pregnancy outcomes have improved over time, in parallel with the increased use of biologic DMARDs during pregnancy.
Like
Save
Share